Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year GlaxoSmithKline PLC had net income fall -89.17% from 8.42bn to 912.00m despite a 16.58% increase in revenues from 23.92bn to 27.89bn.
Gross margin68.39%
Net profit margin6.66%
Operating margin12.37%
Return on assets3.40%
Return on equity74.13%
Return on investment5.27%
More ▼

Cash flow in GBPView more

In 2016, cash reserves at GlaxoSmithKline PLC fell by 881.00m. However, the company earned 6.50bn from its operations for a Cash Flow Margin of 23.30%. In addition the company used 1.27bn on investing activities and also paid 6.39bn in financing cash flows.
Cash flow per share0.6371
Price/Cash flow per share25.14
Book value per share0.3486
Tangible book value per share-4.68
More ▼

Balance sheet in GBPView more

GlaxoSmithKline PLC has a Debt to Total Capital ratio of 76.63%, a lower figure than the previous year's 560.86%.
Current ratio0.895
Quick ratio0.6062
Total debt/total equity10.70
Total debt/total capital0.7663
More ▼

Growth rates in GBP

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -89.20%. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is below the industry average.
Div yield(5 year avg)0.05%
Div growth rate (5 year)2.71%
Payout ratio (TTM)232.52%
EPS growth(5 years)-28.87
EPS (TTM) vs
TTM 1 year ago
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.